Friday, July 11, 2025

Creating liberating content

Ghee coffee is a traditional Ayurvedic drink that’s gaining popularity

First off, eggs are loaded with protein and your hair

Back pain is generally caused sue to muscle soreness or

Bone cancer is a serious condition where abnormal cells grow

Related News

Ghee coffee is a traditional Ayurvedic drink that’s gaining popularity for its potential health benefits. This unique blend of coffee, ghee, and sometimes coconut oil or spices, offers a range

First off, eggs are loaded with protein and your hair is basically made of protein (keratin, if you wanna get fancy). They also pack a punch with vitamins like biotin,

Back pain is generally caused sue to muscle soreness or muscle pull and so it can worsen or improve depending on your posture or body movements, like bending, sitting, or

Bone cancer is a serious condition where abnormal cells grow in the bones, damaging healthy tissues. It can occur in any bone, but often affects the thigh, shin, or upper

In this photo illustration a Bitcoin logo seen displayed on a smartphone with stock market percentages in the background. Omar Marques | SOPA Images | LightRocket | Getty Images Bitcoin

In the yogic tradition, if you cook anything, it must be consumed within 1.5 hours of cooking. And if not, then maximum 4 hours, depending upon the items and cooking

Trending News

‘The Best You’ features India’s comedy queen, Bharti Singh, who shares her story resilience and reinvention Klook, Asia’s leading platform for travel experiences and services, launched its new campaign titled

Britain’s economy contracted for the second consecutive month in May, dealing a blow to finance minister Rachel Reeves as she navigates a shaky domestic recovery and heightened global uncertainty. Official

Slow US-China trade deal may push Trump’s tariff deadlines Trade deals between the US and China are moving at a pace slower than expected, which may lead to extensions of

Access Denied You don’t have permission to access ” on this server. Reference #18.adf5d217.1752215691.16ea1cd4 Source link

Tesla’s entry into India comes at a time when the EV maker is facing reduced sales in Europe and China. (AI image) Elon Musk-led Tesla is set to open its

Market movements are expected to be influenced by India-US trade negotiations and company earnings reports. (AI image) Stock market today: Nifty50 and BSE Sensex, the Indian equity benchmark indices, opened

Dr Reddy’s receives two USFDA observations for New York API facility

Word Count: 726 | Estimated Reading Time: 4 minutes


Dr Reddy's receives two USFDA observations for New York API facility

Dr Reddy’s Laboratories announced on Saturday that the United States Food and Drug Administration (USFDA) has issued a Form 483 with two observations following an inspection of its API (Active Pharmaceutical Ingredients) manufacturing facility in Middleburgh, New York.In a regulatory filing, the Hyderabad-based pharmaceutical company stated that the GMP (Good Manufacturing Practice) inspection was carried out between May 12 and May 16, 2025, news agency PTI reported.“At the conclusion of the inspection, we received a Form 483 with two observations, which we will address within the stipulated timeline,” the company said.According to the USFDA, a Form 483 is issued when inspectors identify conditions that may potentially violate the Food, Drug, and Cosmetic (FD&C) Act or related regulations. The observations are shared with a firm’s management to prompt corrective action.On May 16, Dr Reddy’s Laboratories Ltd closed at Rs 1,228.50, marking a decline of Rs 7.80 or 0.63% from the previous trading session. Earlier on Friday, Dr Reddy’s Laboratories had reported a 21 per cent year-on-year increase in consolidated net profit to Rs 1,587 crore for the quarter ended March 2025, driven by strong sales across key markets such as the US and India. The Hyderabad-based pharmaceutical company had recorded a net profit of Rs 1,307 crore in the same quarter of the previous year. Revenue for the January–March quarter had risen to Rs 8,506 crore, compared to Rs 7,083 crore a year earlier, according to a regulatory filing. For the full financial year 2024–25, Dr Reddy’s had posted a net profit of Rs 5,724 crore, marking a modest 3 per cent growth over the Rs 5,568 crore reported in FY24. The company’s annual revenue had increased to Rs 32,553 crore from Rs 27,916 crore in the preceding fiscal.India’s Pharma sectorIndia’s pharmaceutical industry, a major supplier to the United States, is likely to come under increasing pressure amid heightened regulatory scrutiny. In FY24, the US accounted for $8.7 billion of India’s total pharma exports of $27.9 billion, according to the Pharmaceuticals Export Promotion Council of India. More than 45% of the generic drugs used in the US are manufactured in India, underscoring the country’s crucial role in the American healthcare system, according to an ET report. Additionally, Indian firms supply approximately 15% of the biosimilars consumed in the US. Leading companies such as Sun Pharma, Dr Reddy’s, Aurobindo Pharma, Zydus Lifesciences, and Gland Pharma generate up to half of their revenues from the US market, making them particularly sensitive to regulatory developments.





Source link

Most Popular Articles

Sign In

Welcome ! Log into Your Account